Merck & Co (MSD) has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in Delaware, US.

MSD has reported outcomes from a Phase III trial of Keytruda (pembrolizumab) for treating head and neck squamous cell ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Major pharmaceutical companies showcase the industry's role as a driving force for innovation, development, and the adoption ...

Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

While pharma manufacturing deals in the US increased, large cuts to research and regulatory agencies increased concerns for ...

Assam introduces mobile medical units, including a unique boat unit, to provide essential healthcare services to underserved ...

Mobile medical units, including one on a boat, were launched in Assam on Tuesday by a pharmaceutical major in partnership with an NGO, with a target to reach over 25,000 beneficiaries annually. The ...

When Roy Bradley was told he had cancer in his lungs and liver, his first thought was he couldn't face chemotherapy and ...

Newly released correspondence shows Pfizer told Taoiseach Micheál Martin that Ireland was an “outlier” in not opposing ...

Kelun-Biotech has become the second drugmaker to ... Daiichi's was re-filed for EGFR-positive NSCLC only. Outside China, MSD has rights to sac-TMT under the terms of a partnership signed in ...

The government has established a new subsidiary to oversee the local production of medicines and medical equipment in the ...